Literature DB >> 28049696

Endothelium-Derived C-Type Natriuretic Peptide Contributes to Blood Pressure Regulation by Maintaining Endothelial Integrity.

Kazuhiro Nakao1, Koichiro Kuwahara2, Toshio Nishikimi1, Yasuaki Nakagawa1, Hideyuki Kinoshita1, Takeya Minami1, Yoshihiro Kuwabara1, Chinatsu Yamada1, Yuko Yamada1, Takeshi Tokudome1, Chiaki Nagai-Okatani1, Naoto Minamino1, Yoko M Nakao1, Shinji Yasuno1, Kenji Ueshima1, Masakatsu Sone1, Takeshi Kimura1, Kenji Kangawa1, Kazuwa Nakao1.   

Abstract

We previously reported the secretion of C-type natriuretic peptide (CNP) from vascular endothelial cells and proposed the existence of a vascular natriuretic peptide system composed of endothelial CNP and smooth muscle guanylyl cyclase-B (GC-B), the CNP receptor, and involved in the regulation of vascular tone, remodeling, and regeneration. In this study, we assessed the functional significance of this system in the regulation of blood pressure in vivo using vascular endothelial cell-specific CNP knockout and vascular smooth muscle cell-specific GC-B knockout mice. These mice showed neither the skeletal abnormality nor the early mortality observed in systemic CNP or GC-B knockout mice. Endothelial cell-specific CNP knockout mice exhibited significantly increased blood pressures and an enhanced acute hypertensive response to nitric oxide synthetase inhibition. Acetylcholine-induced, endothelium-dependent vasorelaxation was impaired in rings of mesenteric artery isolated from endothelial cell-specific CNP knockout mice. In addition, endothelin-1 gene expression was enhanced in pulmonary vascular endothelial cells from endothelial cell-specific CNP knockout mice, which also showed significantly higher plasma endothelin-1 concentrations and a greater reduction in blood pressure in response to an endothelin receptor antagonist than their control littermates. By contrast, vascular smooth muscle cell-specific GC-B knockout mice exhibited blood pressures similar to control mice, and acetylcholine-induced vasorelaxation was preserved in their isolated mesenteric arteries. Nonetheless, CNP-induced acute vasorelaxation was nearly completely abolished in mesenteric arteries from vascular smooth muscle cell-specific GC-B knockout mice. These results demonstrate that endothelium-derived CNP contributes to the chronic regulation of vascular tone and systemic blood pressure by maintaining endothelial function independently of vascular smooth muscle GC-B.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  C-type natriuretic peptide; blood pressure; endothelial function; endothelin; endothelium; guanylyl cyclase-B

Mesh:

Substances:

Year:  2017        PMID: 28049696     DOI: 10.1161/HYPERTENSIONAHA.116.08219

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  23 in total

1.  The Protective Role of Natriuretic Peptide Receptor 2 against High Salt Injury in the Renal Papilla.

Authors:  George J Dugbartey; Breandan Quinn; Lingfeng Luo; Deanne M Mickelsen; Sara K Ture; Craig N Morrell; Jan Czyzyk; Marvin M Doyley; Chen Yan; Bradford C Berk; Vyacheslav A Korshunov
Journal:  Am J Pathol       Date:  2019-06-18       Impact factor: 4.307

2.  Relaxing With C-Type Natriuretic Peptide, the Guanylyl Cyclase B Receptor, and Pericytes.

Authors:  S Jeson Sangaralingham; John C Burnett
Journal:  Circulation       Date:  2018-07-31       Impact factor: 29.690

3.  Endothelial C-Type Natriuretic Peptide Is a Critical Regulator of Angiogenesis and Vascular Remodeling.

Authors:  Kristen J Bubb; Aisah A Aubdool; Amie J Moyes; Sarah Lewis; Jonathan P Drayton; Owen Tang; Vedanta Mehta; Ian C Zachary; David J Abraham; Janice Tsui; Adrian J Hobbs
Journal:  Circulation       Date:  2019-03-26       Impact factor: 29.690

4.  C53: A novel particulate guanylyl cyclase B receptor activator that has sustained activity in vivo with anti-fibrotic actions in human cardiac and renal fibroblasts.

Authors:  Yang Chen; Ye Zheng; Seethalakshmi R Iyer; Gerald E Harders; Shuchong Pan; Horng H Chen; Tomoko Ichiki; John C Burnett; S Jeson Sangaralingham
Journal:  J Mol Cell Cardiol       Date:  2019-04-04       Impact factor: 5.000

Review 5.  Physiological and Pathophysiological Effects of C-Type Natriuretic Peptide on the Heart.

Authors:  Akihiro Yasoda
Journal:  Biology (Basel)       Date:  2022-06-14

6.  Circulating osteocrin stimulates bone growth by limiting C-type natriuretic peptide clearance.

Authors:  Yugo Kanai; Akihiro Yasoda; Keita P Mori; Haruko Watanabe-Takano; Chiaki Nagai-Okatani; Yui Yamashita; Keisho Hirota; Yohei Ueda; Ichiro Yamauchi; Eri Kondo; Shigeki Yamanaka; Yoriko Sakane; Kazumasa Nakao; Toshihito Fujii; Hideki Yokoi; Naoto Minamino; Masashi Mukoyama; Naoki Mochizuki; Nobuya Inagaki
Journal:  J Clin Invest       Date:  2017-10-09       Impact factor: 14.808

7.  Increased circulating bioactive C-type natriuretic peptide is associated with reduced heart rate variability in patients with chronic kidney disease.

Authors:  Lulu Wang; Wenjin Liu; Yanting Yu; Lei Jiang; Junwei Yang
Journal:  BMC Nephrol       Date:  2018-03-05       Impact factor: 2.388

8.  Effect of statin therapy on plasma C-type Natriuretic Peptides and Endothelin-1 in males with and without symptomatic coronary artery disease.

Authors:  Timothy C R Prickett; Richard W Troughton; Eric A Espiner
Journal:  Sci Rep       Date:  2020-05-13       Impact factor: 4.379

9.  Prognostic Value of Urinary and Plasma C-Type Natriuretic Peptide in Acute Decompensated Heart Failure.

Authors:  Xiao Ma; Yang Chen; Shawn H Reginauld; Christopher G Scott; Seethalakshmi R Iyer; Jacob J Schaefer; Tomoko Ichiki; Horng H Chen; Andrew D Rule; John C Burnett; S Jeson Sangaralingham
Journal:  JACC Heart Fail       Date:  2021-07-07       Impact factor: 12.544

10.  Overexpression of C-type Natriuretic Peptide in Endothelial Cells Protects against Insulin Resistance and Inflammation during Diet-induced Obesity.

Authors:  Cho-Rong Bae; Jun Hino; Hiroshi Hosoda; Yuji Arai; Cheol Son; Hisashi Makino; Takeshi Tokudome; Tsutomu Tomita; Toru Kimura; Takashi Nojiri; Kiminori Hosoda; Mikiya Miyazato; Kenji Kangawa
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.